Olmesartan HCT Viatris 20/12.5 mg Fimtabletten Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

olmesartan hct viatris 20/12.5 mg fimtabletten

viatris pharma gmbh - olmesartanum medoxomilum, hydrochlorothiazidum - fimtabletten - olmesartanum medoxomilum 20 mg, hydrochlorothiazidum 12.5 mg, carmellosum natricum conexum, mannitolum, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, silica colloidalis anhydrica, magnesii stearas, natrii laurilsulfas, Überzug: hypromellosum, macrogolum 6000, talcum, e 171, pro compresso obducto, natrium 1.4837 mg. - essenziale ipertonia - synthetika

Olmesartan HCT Viatris 20/25 mg Fimtabletten Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

olmesartan hct viatris 20/25 mg fimtabletten

viatris pharma gmbh - olmesartanum medoxomilum, hydrochlorothiazidum - fimtabletten - olmesartanum medoxomilum 20 mg, hydrochlorothiazidum 25 mg, carmellosum natricum conexum, mannitolum, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, silica colloidalis anhydrica, magnesii stearas, natrii laurilsulfas, Überzug: hypromellosum, macrogolum 6000, talcum, e 171, e 172 (flavum), e 172 (rubrum), pro compresso obducto, natrium 2.9674 mg. - essenziale ipertonia - synthetika

Olmesartan HCT Viatris 40/12.5 mg Fimtabletten Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

olmesartan hct viatris 40/12.5 mg fimtabletten

viatris pharma gmbh - olmesartanum medoxomilum, hydrochlorothiazidum - fimtabletten - olmesartanum medoxomilum 40 mg, hydrochlorothiazidum 12.5 mg, carmellosum natricum conexum, mannitolum, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, silica colloidalis anhydrica, magnesii stearas, natrii laurilsulfas, Überzug: hypromellosum, macrogolum 6000, talcum, e 171, e 172 (flavum), e 172 (rubrum), pro compresso obducto, natrium 2.9674 mg. - essenziale ipertonia - synthetika

Olmesartan HCT Viatris 40/25 mg Fimtabletten Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

olmesartan hct viatris 40/25 mg fimtabletten

viatris pharma gmbh - olmesartanum medoxomilum, hydrochlorothiazidum - fimtabletten - olmesartanum medoxomilum 40 mg, hydrochlorothiazidum 25 mg, carmellosum natricum conexum, mannitolum, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, silica colloidalis anhydrica, magnesii stearas, natrii laurilsulfas, Überzug: hypromellosum, macrogolum 6000, talcum, e 171, pro compresso obducto, natrium 2.9674 mg. - essenziale ipertonia - synthetika

OLMESARTAN MEDOXOMIL E IDROCLOROTIAZIDE PENSA Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

olmesartan medoxomil e idroclorotiazide pensa

towa pharmaceutical s.p.a. - olmesartan medoxomil e diuretici - olmesartan medoxomil e diuretici

OLMESARTAN MEDOXOMIL E IDROCLOROTIAZIDE ACCORD Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

olmesartan medoxomil e idroclorotiazide accord

accord healthcare, s.l.u. - olmesartan medoxomil e diuretici - olmesartan medoxomil e diuretici

Olmesartan-HCT-Mepha Teva 20/12.5 mg Compresse rivestite con film Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

olmesartan-hct-mepha teva 20/12.5 mg compresse rivestite con film

mepha pharma ag - hydrochlorothiazidum - compresse rivestite con film - olmesartanum medoxomilum 20.0 mg, hydrochlorothiazidum 12.5 mg, lactosum monohydricum 138.55 mg, hydroxypropylcellulosum substitutum humile, hydroxypropylcellulosum, cellulosum microcristallinum, magnesii stearas, Überzug: hypromellosum, titanii dioxidum, lactosum monohydricum 1.386 mg, macrogolum 3350, triacetinum, e 172 (flavum), e 172 (rubrum), e 110 0.003 mg, pro compresso obducto. - essenziale ipertonia - synthetika

Olmesartan-HCT-Mepha Teva 20/25 mg Compresse rivestite con film Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

olmesartan-hct-mepha teva 20/25 mg compresse rivestite con film

mepha pharma ag - hydrochlorothiazidum - compresse rivestite con film - olmesartanum medoxomilum 20.0 mg, hydrochlorothiazidum 25.0 mg, lactosum monohydricum 126.05 mg, hydroxypropylcellulosum substitutum humile, hydroxypropylcellulosum, cellulosum microcristallinum, magnesii stearas, Überzug: hypromellosum, titanii dioxidum, lactosum monohydricum 1.386 mg, macrogolum 3350, triacetinum, e 172 (flavum), e 172 (rubrum), pro compresso obducto. - essenziale ipertonia - synthetika

Olmesartan-HCT-Mepha Teva 40/12.5 mg Compresse rivestite con film Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

olmesartan-hct-mepha teva 40/12.5 mg compresse rivestite con film

mepha pharma ag - hydrochlorothiazidum - compresse rivestite con film - olmesartanum medoxomilum 40.0 mg, hydrochlorothiazidum 12.5 mg, lactosum monohydricum 289.60 mg, hydroxypropylcellulosum substitutum humile, hydroxypropylcellulosum, cellulosum microcristallinum, magnesii stearas, Überzug: hypromellosum, titanii dioxidum, lactosum monohydricum 2.772 mg, macrogolum 3350, triacetinum, e 172 (flavum), e 172 (rubrum), e 110 0.007 mg, pro compresso obducto. - essenziale ipertonia - synthetika

Olmesartan-HCT-Mepha Teva 40/25 mg Compresse rivestite con film Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

olmesartan-hct-mepha teva 40/25 mg compresse rivestite con film

mepha pharma ag - hydrochlorothiazidum - compresse rivestite con film - olmesartanum medoxomilum 40.0 mg, hydrochlorothiazidum 25.0 mg, lactosum monohydricum 277.10 mg, hydroxypropylcellulosum substitutum humile, hydroxypropylcellulosum, cellulosum microcristallinum, magnesii stearas, Überzug: hypromellosum, titanii dioxidum, lactosum monohydricum 2.772 mg, macrogolum 3350, triacetinum, e 172 (flavum), e 172 (rubrum), pro compresso obducto. - essenziale ipertonia - synthetika